Exegi pharma, llc.

ExeGi Pharma, LLC: Revolutionizing the Biotechnology Industry with Live Biotherapeutic and Probiotic Medicines

ExeGi Pharma, LLC is a biotechnology company that specializes in the development and commercialization of live biotherapeutic and probiotic medicines. The company was founded in 2013 by a team of experienced scientists who recognized the potential of these innovative therapies to revolutionize the treatment of various diseases.

Live biotherapeutic medicines (LBMs) are defined as living microorganisms that are used to prevent or treat diseases. These microorganisms can be bacteria, viruses, or fungi that are naturally present in our bodies. LBMs work by restoring the balance of microorganisms in our gut microbiome, which plays a crucial role in maintaining our overall health.

Probiotics are another type of live microorganism that have been shown to provide numerous health benefits. They are commonly found in fermented foods like yogurt and kefir but can also be taken as supplements. Probiotics work by improving digestion, boosting immunity, and reducing inflammation.

ExeGi Pharma is at the forefront of developing LBMs and probiotics for various medical conditions such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), Clostridium difficile infection (CDI), and other gastrointestinal disorders. The company's flagship product is Visbiome®, a high-potency probiotic supplement containing eight strains of beneficial bacteria.

Visbiome® has been clinically proven to improve symptoms associated with IBD such as abdominal pain, bloating, diarrhea, and constipation. It has also been shown to reduce inflammation markers in patients with ulcerative colitis (UC) and Crohn's disease (CD). Visbiome® is available over-the-counter without a prescription but should be used under medical supervision for optimal results.

In addition to Visbiome®, ExeGi Pharma has several other products under development for various medical conditions. The company's research and development team is constantly exploring new ways to harness the power of LBMs and probiotics to improve human health.

ExeGi Pharma's commitment to quality and safety is evident in its manufacturing processes. The company adheres to strict Good Manufacturing Practices (GMP) guidelines, ensuring that its products are of the highest quality. ExeGi Pharma also conducts rigorous testing on all its products to ensure their safety and efficacy.

ExeGi Pharma has received numerous accolades for its innovative work in the biotechnology industry. In 2019, the company was named one of Maryland's top 50 fastest-growing companies by the Baltimore Business Journal. ExeGi Pharma has also been recognized for its commitment to sustainability, using eco-friendly packaging materials for its products.

In conclusion, ExeGi Pharma is a biotechnology company that is changing the face of medicine with its innovative live biotherapeutic and probiotic medicines. Its flagship product Visbiome® has already helped thousands of patients suffering from IBD, CDI, and other gastrointestinal disorders. With a strong focus on research and development, ExeGi Pharma is poised to make even greater strides in improving human health in the years ahead.